hepurposeofthisreportwastoupdatethe2006InternationalLeagueAgainstEpilepsy(ILAE)reportandidentifythelevelofevidenceforlong-termefficacyoreffectivenessforantiepilepticdrugs(AEDs)asinitialmonotherapyforpatientswithnewlydiagnosedoruntreatedepilepsy.AllapplicablearticlesfromJuly2005untilMarch2012wereidentified,evaluated,andcombinedwiththepreviousysis(Glauseretal.,2006)toprovideacomprehensiveupdate.
Thepriorysismethodologywasutilizedwiththreemodifications:(1)thedetectablenoninferiorityboundaryapproachwasdroppedandbothfailedsuperioritystudiesandprespecifiednoninferioritystudieswereyzedusinganoninferiorityapproach,(2)thedefinitionofanadequatecomparatorwasclarifiedandnowincludesanabsoluteminimumpointestimateforefficacy/effectiveness,and(3)therelationshiptablebetweenclinicaltrialratings,levelofevidence,andconclusionsnolongerincludesarecommendationcolumntoreinforcethatthisreviewofefficacy/evidenceforspecificseizuretypesdoesnotimplytreatmentrecommendations.
Thisevidencereviewcontainsoneclarification:ThecommissionhasdeterminedthatclassIsuperioritystudiescanbedesignedtodetectuptoa20?solute(ratherthanrelative)differenceinthepointestimateofefficacy/effectivenessbetweenstudytreatmentandcomparatorusinganintent-to-treatysis.SinceJuly,2005,threeclassIrandomizedcontrolledtrials(RCT)and11classIIIRCTshebeenpublished.Thecombinedysis(1940-2012)nowincludesatotalof64RCTs(7withclassIevidence,2withclassIIevidence)and11meta-yses.
Newefficacy/effectivenessfindingsincludethefollowing:levetiracetamandzonisamidehelevelAevidenceinswithpartialonsetseizuresandbothethosuximideandvalproicacidhelevelAevidenceinchildrenwithchildhoodabsenceepilepsy.
Therearenomajorchangesinthelevelofevidenceforanyothersubgroup.LevetiracetamandzonisamidejoincarbamazepineandphenytoinwithlevelAefficacy/effectivenessevidenceasinitialmonotherapyforswithpartialonsetseizures.AlthoughethosuximideandvalproicacidnowhelevelAefficacy/effectivenessevidenceasinitialmonotherapyforchildrenwithabsenceseizures,therecontinuestobeanalarminglackofwelldesigned,properlyconductedepilepsyRCTsforpatientswithgeneralizedseizures/epilepsiesandinchildreningeneral.
Thesefindingsreinforcetheneedformulticenter,multinationaleffortstodesign,conduct,andyzefutureclinicallyrelevantadequatelydesignedRCTs.Whenselectingapatient'sAED,allrelevantvariablesandnotjustefficacyandeffectivenessshouldbeconsidered.
查看信源地址
编辑:jiang上一页:北京癫痫手术费用
下一页:癫痫猝死:凶手是谁?
- 2022-04-13心理百科:春节期间小心疾病
- 2022-04-11手术学习:颅内脊索瘤内镜下三脑室入路治疗
- 2022-04-07癫痫治疗障碍仍难以克服
- 2022-04-06月经性癫痫患者妊娠期癫痫控制更好
- 2022-04-05癫痫猝死:凶手是谁?
- 2022-04-042013国际抗癫痫联合会抗癫痫药用指南
- 综述:癫痫持续状态诊治最新进展
- 手术学习:颅内脊索瘤内镜下三脑室入路治疗
- FDA批准Aptiom用于治疗患者癫痫发作
- 癫痫治疗障碍仍难以克服
- 月经性癫痫患者妊娠期癫痫控制更好
- 癫痫猝死:凶手是谁?
- 2013国际抗癫痫联合会抗癫痫药用指南
- 北京癫痫手术费用
- 心率多少正常 如何保持正常心率不变
- 癫痫发作对中风患者静脉溶栓的长期转移有效
- FDA批准开浦兰治疗1个月至4岁癫痫儿童
- 【用药情报站】临床应用应听取各种药种药物禁忌证?
- Medpage Today:不同类型的抗癫痫药物更有利
- DCR: 慢性肾病对局部晚期直肠癌患者接受新辅助放化疗的预后影响
- 三庚酸酯可治疗1型转运体缺陷综合征
- 癫痫治愈费用
- 第四届全国临床脑电图实践基础理论与实践操作培训班
- 世界癫痫日 | 科学防治 标准诊疗 告别癫痫
- Neurology:颅脑损伤增加了迟发性癫痫的风险,高损伤频率、重伤、老年人尤其是
- 2016AAN:神经专家发表了有前途的专业见解
- 罕见病例:自发性颞极性扩张伴癫痫发作
- 英国竞争监管机构指控辉瑞癫痫药品价格过高
- 2015第31届国际癫痫大会(IEC)
- 羊角风有什么症状?
- 泡温泉时不能忽视的事情
- Circ Ep:左室肥厚高血压患者新发房颤增加SCD风险
- UCB的Vimpat癫痫新适应症在美国获批
- 惹来癫痫病发作的因素有哪些
- 癫痫病的病征及治疗
- 放射治疗癫痫病的最佳方法如何能治好
- 脑瘫引起的癫痫要怎么治疗法?
- 痉挛疾病的检查诊断方法有哪些 痉挛疾病的检查费用高吗
- 哮喘患者停药难题有解了?最新预测模型出炉!
- 先天性癫痫病的病症有哪些
- 第九届 CAAE 国际癫痫交流会圆满举行,中国抗癫痫事业开启新篇章
- 略微癫痫病要花多少钱
- 癫痫病最近治疗方法吃什么药啊?
- 日治时代好癫痫病比较好的方法是什么
- 羊角风的诊断对治疗会有什么制约
- 癫痫病诊断的依据是什么